SG11201503247UA - Process for preparing bile acid derivatives - Google Patents

Process for preparing bile acid derivatives

Info

Publication number
SG11201503247UA
SG11201503247UA SG11201503247UA SG11201503247UA SG11201503247UA SG 11201503247U A SG11201503247U A SG 11201503247UA SG 11201503247U A SG11201503247U A SG 11201503247UA SG 11201503247U A SG11201503247U A SG 11201503247UA SG 11201503247U A SG11201503247U A SG 11201503247UA
Authority
SG
Singapore
Prior art keywords
acid derivatives
bile acid
preparing bile
preparing
derivatives
Prior art date
Application number
SG11201503247UA
Other languages
English (en)
Inventor
Roberto Pellicciari
Antimo Gioiello
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of SG11201503247UA publication Critical patent/SG11201503247UA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
SG11201503247UA 2012-10-26 2013-10-25 Process for preparing bile acid derivatives SG11201503247UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
SG11201503247UA true SG11201503247UA (en) 2015-06-29

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201503247UA SG11201503247UA (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Country Status (21)

Country Link
US (2) US9777038B2 (zh)
EP (1) EP2912013B1 (zh)
JP (1) JP6272888B2 (zh)
KR (1) KR102068381B1 (zh)
CN (2) CN108250264A (zh)
AU (1) AU2013334122B2 (zh)
BR (1) BR112015009395A2 (zh)
CA (1) CA2889592A1 (zh)
CY (1) CY1119731T1 (zh)
DK (1) DK2912013T3 (zh)
ES (1) ES2655034T3 (zh)
HK (2) HK1253301A1 (zh)
HU (1) HUE036887T2 (zh)
IL (1) IL238454B (zh)
MX (1) MX361653B (zh)
NO (1) NO2968302T3 (zh)
NZ (2) NZ707389A (zh)
PL (1) PL2912013T3 (zh)
PT (1) PT2912013T (zh)
SG (1) SG11201503247UA (zh)
WO (1) WO2014066819A1 (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201503247UA (en) 2012-10-26 2015-06-29 Intercept Pharmaceuticals Inc Process for preparing bile acid derivatives
EP3149019B1 (en) * 2014-05-29 2019-12-04 Bar Pharmaceuticals S.r.l. Cholane derivatives for use in the treatment and/or prevention of fxr and tgr5/gpbar1 mediated diseases
KR102526632B1 (ko) 2014-11-19 2023-04-27 엔제트피 유케이 리미티드 스테로이드 FXR 조절인자를 제조하기 위한 중간체로서의 5β-6-알킬-7-하이드록시-3-온 스테로이드
EP3221334B1 (en) 2014-11-19 2020-02-19 Nzp Uk Limited 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
CN107207559B (zh) 2014-11-19 2019-10-25 Nzp英国有限公司 作为制备类固醇fxr调节剂的中间体的6-烷基-7-羟基-4-烯-3-酮类固醇
TWI686401B (zh) 2014-11-19 2020-03-01 英商Nzp英國有限公司 化合物(三)
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
CA2976056C (en) 2015-02-06 2024-02-06 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions for combination therapy
AU2016325619A1 (en) * 2015-09-24 2018-04-12 Intercept Pharmaceuticals, Inc. Methods and intermediates for the preparation bile acid derivatives
AU2016350690C1 (en) * 2015-11-06 2020-04-23 Intercept Pharmaceuticals, Inc. Methods for the preparation of obeticholic acid and derivatives thereof
WO2017142895A1 (en) * 2016-02-15 2017-08-24 Regents Of The University Of Minnesota Compositions and methods for treating clostridium associated diseases
JP6968821B2 (ja) 2016-04-13 2021-11-17 インターセプト ファーマシューティカルズ, インコーポレイテッド 癌を治療する方法
TW201738254A (zh) * 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
KR20190057108A (ko) * 2016-09-30 2019-05-27 인터셉트 파마슈티컬즈, 인크. 담즙산 유도체의 결정형
MX2020000873A (es) 2017-07-24 2020-07-22 Intercept Pharmaceuticals Inc Derivados de ácidos biliares marcados isotópicamente.
JP7308811B2 (ja) 2017-07-26 2023-07-14 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド ステロイド系誘導体fxrアゴニストの製造方法
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
KR20220016146A (ko) 2019-05-30 2022-02-08 인터셉트 파마슈티컬즈, 인크. 담즙정체성 간 질환의 치료에서 사용하기 위한 fxr 효능제 및 피브레이트를 포함하는 제약 조성물
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
EP4215540A1 (en) 2020-09-18 2023-07-26 Seoul National University R & DB Foundation Method for mass-producing sodium taurodeoxycholate

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) * 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
USRE48286E1 (en) * 2001-03-12 2020-10-27 Intercept Pharmaceuticals, Inc. Steroids as agonists for FXR
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
WO2008002573A2 (en) * 2006-06-27 2008-01-03 Intercept Pharmaceuticals, Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
EP2303026B1 (en) * 2008-06-17 2020-09-09 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
WO2010014836A2 (en) * 2008-07-30 2010-02-04 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
CN106380502A (zh) * 2008-11-19 2017-02-08 英特塞普特医药品公司 G蛋白偶联受体5(tgr5)调节剂及其使用方法
SG11201503247UA (en) 2012-10-26 2015-06-29 Intercept Pharmaceuticals Inc Process for preparing bile acid derivatives

Also Published As

Publication number Publication date
PT2912013T (pt) 2018-01-03
CN108250264A (zh) 2018-07-06
DK2912013T3 (en) 2018-01-15
IL238454B (en) 2018-11-29
IL238454A0 (en) 2015-06-30
JP6272888B2 (ja) 2018-01-31
HK1253301A1 (zh) 2019-06-14
EP2912013A1 (en) 2015-09-02
US10202414B2 (en) 2019-02-12
PL2912013T3 (pl) 2018-05-30
MX2015005286A (es) 2015-10-29
MX361653B (es) 2018-12-13
EP2912013A4 (en) 2016-06-01
NZ745013A (en) 2019-08-30
AU2013334122A1 (en) 2015-05-14
NO2968302T3 (zh) 2018-02-03
BR112015009395A2 (pt) 2017-07-04
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
US20150291653A1 (en) 2015-10-15
NZ707389A (en) 2018-08-31
CN105102425A (zh) 2015-11-25
CY1119731T1 (el) 2018-06-27
US9777038B2 (en) 2017-10-03
US20180079776A1 (en) 2018-03-22
WO2014066819A1 (en) 2014-05-01
JP2015533852A (ja) 2015-11-26
KR102068381B1 (ko) 2020-01-20
ES2655034T3 (es) 2018-02-16
CN105102425B (zh) 2018-04-10
CA2889592A1 (en) 2014-05-01
KR20150074062A (ko) 2015-07-01
AU2013334122B2 (en) 2017-11-02
EP2912013B1 (en) 2017-10-11

Similar Documents

Publication Publication Date Title
HK1214239A1 (zh) 製備膽汁酸衍生物的方法
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
SG11201503291RA (en) Process for producing acetic acid
HK1201517A1 (zh) 製備喹啉衍生物的方法
IL238314A (en) Process for the preparation of an important compound of linagliptin
IL238139A0 (en) A process for the production of suspended starch
IL222290A0 (en) Process for preparing aminobenzofuran derivatives
IL222191A0 (en) Process for preparing sulfonamido-benzofuran derivatives
IL227872A0 (en) A process for the preparation of n-converted phenylhydroxylamines
SG11201504643WA (en) Integrated process for making acetic acid
IL235802A0 (en) A new process for the preparation of 2-cyclopentyl-6-methoxy-isonicotinic acid
SG11201403205SA (en) Process for making levulinic acid
HRP20181931T1 (hr) Kontinuirani proces za pripravu (s)-2-acetiloksipropionske kiseline
IL233945A0 (en) A method for the production of modified anthranilic acid precursors
IL227220A (en) A process for preparing a history of 3-alkylsulfinylbenzoyl
HK1204607A1 (zh) 製備 -氨基- -聯苯- -基- -羥甲基- -甲基-戊酸化合物的方法
EP2855433A4 (en) PROCESS FOR THE PREPARATION OF DIHALOPYRIDINES
EP2819995A4 (en) PROCESS FOR THE PREPARATION OF 3-METHYLSULFONYLPROPIONITRIL
IL239136A0 (en) A method for the production of derivatives of 3-mercapto-4-haloalkyl substituted 2-hydroxy-benzoic acid
EP2857510A4 (en) PROCESS FOR PREPARING 3-ACETYLAMINO-4-HYDROXYBENZOIC ACID
GB201223319D0 (en) Process for producing lactic acid
IL238934A (en) Methods for making phenyloxymethyl-nitro-imidazole derivatives